title: Tissue distribution and efficacy of gold nanorods coupled with laser induced photoplasmonic therapy in ehrlich carcinoma solid tumor model.
abstract: Gold nanorods (GNR) within tumor microregions are characterized by their ability to absorb near IR light and emit heat in what is called photoplasmonic effect. Yet, the efficacy of nanoparticles is limited due to intratumoral tissue distribution reasons. In addition, distribution of GNRs to normal tissue might result in non specific toxicity. In the current study, we are assessing the intratumoral and tissue distribution of PEGylated GNRs on the top of its antitumor characteristics when given intravenously or intratumoral to solid tumor bearing mice and coupled with laser photoplasmonic sessions. PEGylated GNRs with a longitudinal size of less than 100 nm were prepared with aspect ratio of 4.6 showing strong surface plasmon absorption at wavelength 800 nm. Pharmacokinetics of GNR after single I.V. administration (0.1 mg/kg) showed very short systemic circulating time (less than 3 h). On the other hand, tissue distribution of I.V. GNR (0.1 mg/kg) to normal animals showed preferential deposition in spleen tissue. Repeated administration of I.V. GNR resulted in preferential accumulation in both liver and spleen tissues. In addition, I.V. administration of GNR to Ehrlich carcinoma tumor bearing mice resulted in similar tissue distribution; tumor accumulation and anti-tumor effect compared to intratumoral administration. In conclusion, the concentration of GNR achieved within tumors microregions after I.V. administration was comparable to I.T. administration and sufficient to elicit tumoral growth arrest when coupled with laser-aided photoplasmonic treatment.
authors.affiliation: Laser Dynamics Laboratory, School of Chemistry and Biochemistry, Georgia Institute of Technology, Atlanta, Georgia, United States of America.
authors.forename: Mostafa A
authors.initials: MA
authors.lastname: El-Sayed
authors.forename: Ali A
authors.initials: AA
authors.lastname: Shabaka
authors.forename: Osama A
authors.initials: OA
authors.lastname: El-Shabrawy
authors.forename: Nemat A
authors.initials: NA
authors.lastname: Yassin
authors.forename: Sawsan S
authors.initials: SS
authors.lastname: Mahmoud
authors.forename: Siham M
authors.initials: SM
authors.lastname: El-Shenawy
authors.forename: Emad
authors.initials: E
authors.lastname: Al-Ashqar
authors.forename: Wael H
authors.initials: WH
authors.lastname: Eisa
authors.forename: Niveen M
authors.initials: NM
authors.lastname: Farag
authors.forename: Marwa A
authors.initials: MA
authors.lastname: El-Shaer
authors.forename: Nabila
authors.initials: N
authors.lastname: Salah
authors.forename: Ahmed M
authors.initials: AM
authors.lastname: Al-Abd
mesh_terms: D061605:Administration, Intravenous; D000818:Animals; D002286:Carcinoma, Ehrlich Tumor / Q000378:metabolism* / Q000473:pathology / Q000628:therapy; D004195:Disease Models, Animal; D005260:Female; D006046:Gold / Q000737:chemistry; D006979:Hyperthermia, Induced; D028022:Low-Level Light Therapy; D008297:Male; D051379:Mice; D043942:Nanotubes / Q000737:chemistry / Q000648:ultrastructure; D011092:Polyethylene Glycols / Q000737:chemistry; D014018:Tissue Distribution; D047368:Tumor Burden
chemical_list: D011092:Polyethylene Glycols; D006046:Gold